CIRCIUS PHARMA AS
1811 ASKIM
Return on Equity
0Â %
Current Ratio
1,05
Debt-to-Equity Ratio
0
| Key figures (NOK) | 2022 | |
|---|---|---|
| Revenue | 15Â 980Â 000 | |
| Net Income | 0 | |
| Total Assets | 5Â 388Â 000 | |
| Total Equity | 2Â 046Â 000 |
| Income (NOK) | 2022 | |
|---|---|---|
| Revenue | 15Â 980Â 000 | |
| Expenditure | 15Â 972Â 000 | |
| Operating Profit | 7Â 000 | |
| Financial Income | 0 | |
| Financial Costs | 8Â 000 | |
| Financial Balance | −8 000 | |
| Earnings Before Tax | 0 | |
| Tax | 0 | |
| Net Income | 0 |
| Balance (NOK) | 2022 | |
|---|---|---|
| Total Fixed Assets | 1Â 894Â 000 | |
| Total Current Assets | 3Â 494Â 000 | |
| Total Assets | 5Â 388Â 000 | |
| Total Retained Equity | 0 | |
| Total Equity | 2Â 046Â 000 | |
| Total Long-Term Debt | 0 | |
| Total Current Debt | 3Â 342Â 000 | |
| Total Equity and Debt | 5Â 388Â 000 |
| Cash flow (NOK) | 2022 | |
|---|---|---|
| Sales Income | 15Â 969Â 000 | |
| Other Income | 11Â 000 | |
| Revenue | 15Â 980Â 000 | |
| Cost of Goods Sold | 10Â 289Â 000 | |
| Salary Costs | 1Â 383Â 000 | |
| Depreciation | 218Â 000 | |
| Impairment | 0 | |
| Expenditure | 15Â 972Â 000 | |
| Operating Profit | 7Â 000 | |
| Financial Income | 0 | |
| Financial Costs | 8Â 000 | |
| Financial Balance | −8 000 | |
| Dividends | 0 | |
| Net Income | 0 |
| Balance details (NOK) | 2022 | |
|---|---|---|
| Goodwill | 1Â 894Â 000 | |
| Total Intangible Assets | 1Â 894Â 000 | |
| Real Eastate | 0 | |
| Machinery and Plant Facilities | 0 | |
| Fixtures | 0 | |
| Total Tangible Assets | 0 | |
| Total Fiancial Fixed Assets | 0 | |
| Total Fixed Assets | 1Â 894Â 000 | |
| Stock | 0 | |
| Total Investments | 0 | |
| Cash, Bank | 1Â 092Â 000 | |
| Total Current Assets | 3Â 494Â 000 | |
| Total Assets | 5Â 388Â 000 | |
| Total Equity | 2Â 046Â 000 | |
| Short-Term Group Debt | 1Â 285Â 000 | |
| Total Long-Term Debt | 0 | |
| Creditors | 1Â 341Â 000 | |
| Unpaid Taxes | 598Â 000 | |
| Dividends | 0 | |
| Other Current Debt | 118Â 000 | |
| Total Current Debt | 3Â 342Â 000 | |
| Total Equity and Debt | 5Â 388Â 000 |
| Financial indicators | 2022 | |
|---|---|---|
| Return on Equity | 0Â % | |
| Debt-to-Equity Ratio | 0 | |
| Operating Profit Margin | 0,04Â % | |
| Current Ratio | 1,05 | |
| Quick Ratio | 1,05 | |
| Equity Ratio | 0,38 | |
| Gross Profit Margin | 35,61Â % |
Rotate your device to see the full table